Product Name

  • Name

    Omeprazole sodium

  • EINECS 623-285-9
  • CAS No. 95510-70-6
  • Density 1.37g/cm3
  • Solubility
  • Melting Point
  • Formula C17H18N3NaO3S
  • Boiling Point 600oC at 760mmHg
  • Molecular Weight 368.412
  • Flash Point 316.7oC
  • Transport Information
  • Appearance Clear in water
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 95510-70-6 (Omeprazole sodium)
  • Hazard Symbols
  • Synonyms 1H-Benzimidazole,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt (9CI);(±)-Omeprazole sodium salt;5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazolesodium salt;5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-1H-benzimidazolesodium salt;H 168/68 sodium;Losec Sodium;Omeprazolesodium salt;Sodium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]benzoimidazole;
  • PSA 94.68000
  • LogP 3.48690

Omeprazole sodium Specification

The Omeprazole sodium, with the CAS registry number 95510-70-6, is also known as Sodium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]benzoimidazole. It belongs to the product categories of Active Pharmaceutical Ingredients; Omeprazole. This chemical's molecular formula is C17H18N3NaO3S and molecular weight is 368.41. Its classification codes are: (1)Antisecretory [gastric]; (2)Drug / Therapeutic Agent; (3)Reproductive Effect.

Physical properties of Omeprazole sodium are: (1)#H bond acceptors: 6; (2)#H bond donors: 1; (3)#Freely Rotating Bonds: 5; (4)Polar Surface Area: 96.31 Å2.

You can still convert the following datas into molecular structure:
(1)SMILES: [Na+].Cc3c(OC)c(C)cnc3CS(=O)c1nc2ccc(cc2n1)OC
(2)Std. InChI: InChI=1S/C17H19N3O3S.Na/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17;/h5-8H,9H2,1-4H3,(H,19,20);/q;+1
(3)Std. InChIKey: KNVABRFVZVESIL-UHFFFAOYSA-N

The toxicity data is as follows:  

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo intravenous 400mg/kg (400mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
Oyo Yakuri. Pharmacometrics. Vol. 49, Pg. 497, 1995.
rat LD50 intravenous 278mg/kg (278mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Oyo Yakuri. Pharmacometrics. Vol. 49, Pg. 479, 1995.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View